RPL43A is one of two yeast homologs (RPL43A and RPL43B) of the human ribosomal protein L43 (RPL43). These homologs share 90% DNA sequence identity and 100% amino acid sequence identity . Key functional attributes include:
Structural Localization: RPL43 is positioned near the peptidyl transferase center (PTC) of the ribosome, interacting with Rpl2 and contributing to 7S rRNA production .
Chaperone Interactions: RPL43 forms a trimeric complex with proteins Puf6 and Loc1, which regulate its loading onto the 60S subunit and influence mRNA localization .
| Feature | RPL43A | RPL43B |
|---|---|---|
| DNA Sequence Identity | 90% | 90% |
| Amino Acid Identity | 100% | 100% |
| Functional Role | Ribosomal assembly, mRNA binding | Redundant with RPL43A |
Immunogen Design: Peptides derived from conserved regions (e.g., internal sequences of human RPL3) .
Validation: Western blot (WB), immunohistochemistry (IHC), and ELISA are standard validation methods .
Cross-Reactivity: Antibodies for ribosomal proteins often exhibit cross-species reactivity (e.g., human, mouse, rat) .
Antibodies against ribosomal proteins like RPL3 serve as useful proxies for understanding RPL43A’s potential utility:
Mechanistic Studies:
Disease Associations:
Epitope Selection: Prioritize non-conserved regions to avoid cross-reactivity with RPL43B.
Functional Assays: Assess antibody performance in ribosome profiling or pre-60S subunit immunoprecipitation .
Clinical Relevance: Link RPL43A dysregulation to diseases (e.g., cancers, autoimmune disorders) using validated biomarkers .
KEGG: sce:YJR094W-A
STRING: 4932.YPR043W
RPL43A (Ribosomal Protein L43A) is a component of the 60S subunit of ribosomes, playing a critical role in protein synthesis. This ribosomal protein is highly conserved across species, indicating its evolutionary importance. Research interest in RPL43A has grown due to its potential involvement in various cellular processes beyond protein synthesis, including stress response mechanisms, cell growth regulation, and potential roles in certain pathological conditions. Like other ribosomal proteins such as RPL3, RPL43A may have extraribosomal functions that make it a valuable target for biological research.
RPL43A antibodies can be used with multiple specimen types including:
| Specimen Type | Compatibility | Special Considerations |
|---|---|---|
| Cell lines | High | Optimal for many human, mouse, and rat cell lines |
| Tissue sections | Good | Requires optimization of fixation protocols |
| Tissue lysates | High | Protein extraction buffer selection is critical |
| Primary cells | Good | May require adjustment of antibody concentration |
| Yeast cells | Variable | Species-dependent cross-reactivity |
When working with tissue samples, proper fixation is essential for preserving epitope accessibility. For tissues, paraformaldehyde fixation followed by paraffin embedding typically yields good results, similar to methods used with other ribosomal protein antibodies.
The primary applications for RPL43A antibodies include:
Western blotting (WB): Typically used at 1:500-2000 dilution
Immunohistochemistry (IHC): Effective at 1:50-400 dilution
Immunocytochemistry (ICC): Recommended at 1:50-400 dilution
Immunofluorescence (IF): Optimal at 1:50-400 dilution
Immunoprecipitation (IP): Effective at approximately 1:50 dilution
As with other ribosomal protein antibodies like RPL3, optimization of antibody concentration for each specific application and sample type is essential for obtaining reliable results.
For optimal longevity and activity, store RPL43A antibodies according to these guidelines:
Long-term storage: -20°C to -70°C as supplied (typically stable for 12 months from date of receipt)
Short-term storage (1 month): 2-8°C under sterile conditions after reconstitution
Medium-term storage (6 months): -20°C to -70°C under sterile conditions after reconstitution
It is critical to avoid repeated freeze-thaw cycles, as this can significantly diminish antibody activity. Aliquoting the antibody upon first thaw is recommended for preservation of functionality. These storage recommendations align with those for other ribosomal protein antibodies such as RPL3.
For Western blot applications with RPL43A antibodies, the following blocking protocol is recommended:
After transfer to a nitrocellulose or PVDF membrane, block with 5% non-fat milk in TBS for 1.5 hours at room temperature
Incubate with RPL43A antibody at 1:1000 dilution overnight at 4°C
Wash with TBS-0.1% Tween 3 times for 5 minutes each
Probe with an appropriate secondary antibody (typically anti-rabbit IgG-HRP) at 1:5000 dilution for 1.5 hours at room temperature
Develop using an ECL substrate system
This protocol has been shown to provide optimal signal-to-noise ratio for ribosomal proteins. Using a similar approach to that validated for RPL3 antibodies should yield reliable results.
To verify RPL43A antibody specificity, consider these approaches:
Positive controls: Use cell lines known to express RPL43A (most mammalian cell lines should work)
Negative controls: Include primary antibody omission controls
Knockout/knockdown validation: If available, compare wild-type samples with RPL43A knockout or knockdown samples
Peptide competition assay: Pre-incubate the antibody with excess immunizing peptide to confirm specific binding
Multiple antibody validation: Compare results using antibodies raised against different epitopes of RPL43A
The expected molecular weight for RPL43A is approximately 11-12 kDa; verification should include confirmation of detection at this size.
When investigating post-translational modifications (PTMs) of RPL43A, consider this experimental approach:
Initial screening: Use phospho-specific or methyl-specific antibodies if available, or mass spectrometry to identify potential PTMs
Verification: Employ site-directed mutagenesis to confirm the specific modified residues
Functional analysis: Compare wild-type RPL43A with mutation-mimicking or mutation-preventing variants
Enzyme identification: Use inhibitors or knockout models of potential modifying enzymes to confirm the enzymatic pathway
Similar to studies on RPL42, where methylation at lysine residues was found to be functionally significant, RPL43A may undergo methylation that affects its function. Research on RPL42 demonstrated that methylation deficiency led to stress response defects, and similar approaches could be valuable for RPL43A investigation.
To study RPL43A interactions with other ribosomal components:
Co-immunoprecipitation (Co-IP): Use RPL43A antibodies to pull down the protein complex and identify interacting partners
Proximity ligation assay (PLA): Visualize and quantify protein-protein interactions in situ
Crosslinking mass spectrometry: Identify direct protein-protein contacts within the ribosome
Cryo-EM structural analysis: Determine the spatial relationship between RPL43A and other ribosomal components
Yeast two-hybrid or mammalian two-hybrid assays: Screen for potential interacting partners
When designing these experiments, consider using both intact ribosomes and ribosomal subunits to differentiate between direct and indirect interactions.
For studying RPL43A in stress response pathways:
Stress induction: Apply various stressors (oxidative stress, heat shock, nutrient deprivation) to cells
Temporal analysis: Track changes in RPL43A localization, expression, and modification at multiple time points
Subcellular fractionation: Determine if stress induces relocalization of RPL43A from ribosomes to other cellular compartments
Polysome profiling: Assess how stress affects RPL43A association with actively translating ribosomes
Comparison with known stress markers: Include well-characterized stress response proteins as controls
Research on related ribosomal proteins suggests that methylation can play important roles in stress adaptation, as demonstrated with RPL42, where methylation-deficient mutants showed higher sensitivity to stress conditions and defects in stress-responsive growth control.
When facing contradictory results in RPL43A research:
Validate antibody specificity: Ensure all antibodies used recognize the intended epitopes specifically
Compare experimental conditions: Systematically evaluate differences in cell types, stress conditions, or experimental methods
Account for redundancy: Consider functional overlap with other ribosomal proteins (e.g., RPL43B)
Assess extraribosomal functions: Determine if contradictions arise from non-canonical functions of RPL43A
Genetic background effects: Check for genetic modifiers that might influence phenotypes in different model systems
When designing these validation experiments, include appropriate controls and standardize protocols across different experimental setups to minimize technical variability.
To investigate ribosome heterogeneity using RPL43A antibodies:
Sucrose gradient fractionation: Separate different ribosomal populations and analyze RPL43A distribution
Immunoaffinity purification: Isolate RPL43A-containing ribosomes and characterize their composition and associated mRNAs
Single-cell analysis: Use immunofluorescence to assess cell-to-cell variation in RPL43A incorporation into ribosomes
Tissue-specific analysis: Compare RPL43A-containing ribosomes across different tissues or developmental stages
Translation-specific ribosome profiling: Assess whether RPL43A is enriched in ribosomes translating specific mRNA subsets
This approach can provide insights into specialized ribosomes and their potential roles in regulating translation of specific mRNAs under different conditions.
For accurate quantification of RPL43A expression or modification:
Western blot with internal loading controls: Use housekeeping proteins or total protein staining (e.g., GAPDH, β-actin)
Quantitative real-time PCR: Measure RPL43A mRNA levels using validated reference genes
Mass spectrometry with isotope labeling: For precise quantification of protein abundance and modifications
ELISA: Develop sandwich ELISA for high-throughput quantification
Flow cytometry: For cell-by-cell quantification of RPL43A levels
When analyzing post-translational modifications, consider the ratio of modified to unmodified protein rather than absolute levels alone, as this provides insight into the regulatory dynamics.
For studying ribosome quality control mechanisms:
Co-localization with quality control factors: Assess RPL43A co-localization with factors like ZNF598, PELO, or HBS1L during stress
Ribophagy analysis: Examine RPL43A fate during selective autophagy of ribosomes
Ubiquitination pattern analysis: Determine if and how RPL43A is ubiquitinated during quality control processes
Ribosome collision detection: Use RPL43A antibodies alongside collision markers to study translation quality control
Split fluorescent protein complementation: Monitor real-time interactions between RPL43A and quality control machinery
These approaches can provide insights into how ribosomal proteins like RPL43A participate in or are targeted by quality control mechanisms that maintain translation fidelity.
To investigate RPL43A in aging processes:
Chronological aging models: Compare RPL43A expression, modification, and localization in young versus aged cells
Lifespan assays: Assess how RPL43A mutations affect cellular or organismal lifespan
Senescence marker correlation: Determine relationships between RPL43A status and established senescence markers
Stress resistance correlation: Evaluate how RPL43A modifications affect cellular resistance to age-related stressors
Translation fidelity assays: Measure how age-related changes in RPL43A affect ribosomal accuracy
Research on related ribosomal proteins has demonstrated connections to aging processes. For example, studies with RPL42 methylation-deficient mutants showed reduced ability to survive after entering stationary phase, suggesting a role in chronological aging.
For dynamic imaging of RPL43A:
Super-resolution microscopy: Use techniques like STORM or PALM with RPL43A antibodies for nanoscale localization
Live-cell imaging: Combine with genetically encoded tags (if direct antibody use isn't feasible)
FRET/FLIM analysis: Study dynamic interactions between RPL43A and other proteins
Correlative light and electron microscopy (CLEM): Connect fluorescence localization with ultrastructural context
Lattice light-sheet microscopy: Observe RPL43A dynamics with minimal phototoxicity over extended periods
When designing these experiments, consider appropriate controls to confirm antibody specificity in imaging applications, as background can be problematic in advanced microscopy techniques.